AstraZeneca PLC

AZNNYSE • USD
171.49 USD
↘ 1.08 (0.63%)AT CLOSE (03:59 PM EDT)
170.70
↘ 0.80 (0.46%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
170.70
↘ 0.80 (0.46%)
🔴Market: CLOSED

Shares of AstraZeneca PLC (AZN) are trading at $171.49. AZN shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9 and a bearish Death Cross on the long-term moving averages. On the valuation front, AZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Oct 23, 2026.

Open?$171.28
High?$171.75
Low?$169.51
Prev. Close?$172.57
Volume?3.7M
Avg. Volume?2.9M
VWAP?$171.57
Rel. Volume?1.26x
Bid / Ask
Bid?$168.50 × 100
Ask?$172.89 × 500
Spread?$4.39
Midpoint?$170.70
Valuation & Ratios
Market Cap?266.0B
Shares Out?N/A
P/E Ratio?119.75
P/B Ratio?19.66
EPS?$1.43
Dividend?1.33%
Ex-Dividend?N/A
News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Employees
96.1K
Market Cap
266.0B
Industry
N/A
Listed
2009-10-23
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
97
Momentum?
6
Short Sent.?
43
Piotroski F-Score?2/9Weak
Altman Z-Score?4.69Safe
Confidence?58%Low
Full Fundamental Analysis →
Short InterestLow
Short Interest?2.6M
Days to Cover?1.0
Avg Daily Volume2.8M
Settlement Date2026-09-30
Financial Health
Current Ratio?0.93Weak
Quick Ratio?0.76Weak
Cash Ratio?0.27Low
Debt/Equity?1.40Moderate
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score
33/100
P/E?
Peers
11
S&P
3
119.8PRICEY▾
P/B?
Peers
33
S&P
7
19.66HIGH▾
P/S?
Peers
27
S&P
7
11.05HIGH▾
P/FCF?
Peers
11
S&P
3
116.9PRICEY▾
EV/EBITDA?
Peers
11
S&P
3
52.8HIGH▾
EV/Sales?
Peers
27
S&P
8
11.68HIGH▾
Returns & Efficiency
ROE?
Peers
44
S&P
58
16.4%STRONG▾
ROA?
Peers
44
S&P
31
3.5%FAIR▾
Cash Flow & Enterprise
FCF?$2.3B
Enterprise Value?$281.1B
Fundamentals ratios updated end of day